Tuesday, November 17, 2020

Opening for a Senior Accountant in a Pharma Company near Rabindra Sadan Metro

     


DESIGNATION      : SENIOR ACCOUNTANT
EXPERIENCE          : MINIMUM 10 YEARS.
SALARY - RS. 18 K to 22 K P.M (NOT NEGOTIABLE)
NOTICE - MAXIMUM WITHIN 7 DAYS. 
JOB LOCATION  -  NEAR Rabindra Sadan Metro
Opposite to Exide More
POSITION - ONE
ELIGIBILITY - B COM
JOB CODE: CPSNRSADAN

Working Hours: 10 a.m to 7 p.m

Company Profile :
Pharma Products Manufacturing.


Job Profile :
Assisting in finalization of Accounts.
IT return filing (Individual Accounts)
GST, P TAX and TDS EFILING
Handling a team of 5 accountants

Desired Profile :
Minimum 10 years experience.
Intermediate to advanced experience with 
MS Word, MS Excel, MS Outlook, Tally ERP 9.
Candidate should be presentable with 
good communication skill.


TO HELP US GIVE YOU A PROMPT AND 
POSITIVE REPLY. WHATSAPP US YOUR CV
IN MS WORD FORMAT with

Job Code - CPSNRSADAN

TO 7003358319 (Please do not Call)

*Placement consulting charges is applicable*

(
INTERVIEW VENUE
ECOMM CORPORATE RECRUITMENT SOLUTIONS
(PLACEMENT CONSULTANCY)

REGISTERED OFFICE
7/1 A, GRANT LANE, ROOM NUMBER - 2,
 SECOND FLOOR,
BUS STOPPAGE: LAL BAZAR - BENTINCK STREET.
(SHYAM CHAMBERS), CHAMBER NO 7,
KOLKATA - 700 012. 

NEAREST METRO: BOTH CHANDNI CHOWK (NORTH GATE)
LANDMARK: BESIDE BENTINCK STREET BATA SHOWROOM,
LALBAZAR (B.B.D.BAG), 
GRANT LANE IS OPPOSITE TO MERCANTILE BUILDING IN 
BENTINCK STREET.
SOCIAL NETWORKING FACEBOOK | LINKEDIN

4 comments:

robinjack said...

The quality of data is the most important factor that decides whether an opportunity will be reviewed seriously. While incomplete data can be acceptable, biotech needs to be up front about the deficiencies. No hype is allowed. Pharma prefers to collaborate with knowledgeable counterparties who can realistically share the vision of how to best bring a drug to the patient. buy crystal meth

Douglass drugs said...

New blockbusters replacing those falling off the exclusivity cliff are getting harder to find. Many of the "easy" disease targets are already well addressed, and remaining indications with large patient populations are chronic diseases, often of late life and multi-etiological. Novel target mechanisms often require the focus on smaller patient populations identified through biomarker studies or specific diagnostics. The potential for a more specific response in these patients makes this concept a realistic alternative to the blockbuster model. Some companies have stated that they prefer spreading the risk among multiple smaller products rather than relying on a few blockbusters.
Buy DMT powder online

jackman10 said...

I always visit your blog and retrieve everything you post here but I never commented but today when I saw this post, I couldn’t stop myself from commenting here. Fantastic article mate! Ross Levinsohn

smithseo said...

When I originally commented I clicked the -Notify me when new surveys are added- checkbox and already if a comment is added I purchase four emails with similar comment. Perhaps there is any way it is possible to remove me from that service? Thanks! Ross Levinsohn